Fluticasone Propionate/Salmeterol



Indications and Reactions:

Role Indications Reactions
Primary
Asthma 46.6%
Product Used For Unknown Indication 21.2%
Chronic Obstructive Pulmonary Disease 10.9%
Emphysema 4.3%
Hypertension 4.0%
Pulmonary Fibrosis 2.7%
Bronchitis Chronic 1.2%
Bronchitis 1.0%
Prophylaxis 1.0%
Arrhythmia 0.9%
Angina Pectoris 0.8%
Gastrooesophageal Reflux Disease 0.8%
Nervous System Disorder 0.8%
Osteoporosis 0.6%
Analgesic Asthma Syndrome 0.5%
Bronchiectasis 0.5%
Epilepsy 0.5%
Insomnia 0.5%
Respiratory Tract Infection 0.5%
Rhinitis Allergic 0.5%
Death 18.6%
Asthma 16.0%
Product Quality Issue 16.0%
Drug Ineffective 8.2%
Dysphonia 4.3%
Cough 3.5%
Oesophageal Candidiasis 3.5%
Pneumonia 3.5%
Dyspnoea 3.0%
Pulmonary Fibrosis 3.0%
Oral Candidiasis 2.6%
Overdose 2.6%
Asthmatic Crisis 2.2%
Burning Sensation 2.2%
Pyrexia 2.2%
Acute Myocardial Infarction 1.7%
Bronchitis 1.7%
Headache 1.7%
Neoplasm Malignant 1.7%
Osteonecrosis 1.7%
Secondary
Product Used For Unknown Indication 46.9%
Asthma 27.1%
Chronic Obstructive Pulmonary Disease 9.2%
Respiratory Tract Infection 3.5%
Atrial Fibrillation 1.6%
Hypertension 1.5%
Pyrexia 1.2%
Bronchitis Chronic 1.0%
Hypersensitivity 1.0%
Prophylaxis 0.9%
Respiratory Arrest 0.9%
Hypercholesterolaemia 0.7%
Mental Disorder 0.7%
Pulmonary Arterial Hypertension 0.7%
Depression 0.6%
Anxiety Disorder 0.5%
Cardiac Disorder 0.5%
Maternal Exposure During Pregnancy 0.5%
Panic Disorder 0.5%
Rheumatoid Arthritis 0.5%
Asthma 15.2%
Drug Ineffective 8.7%
Dyspnoea 6.5%
Transient Ischaemic Attack 6.5%
Adrenal Insufficiency 5.4%
Oral Candidiasis 5.4%
Chest Pain 4.3%
Death 4.3%
Hypotension 4.3%
Poisoning 4.3%
Respiratory Tract Infection Fungal 4.3%
Toxicity To Various Agents 4.3%
Abdominal Pain Upper 3.3%
Acth Stimulation Test Abnormal 3.3%
Acute Myocardial Infarction 3.3%
Asthenia 3.3%
Chronic Obstructive Pulmonary Disease 3.3%
Depression 3.3%
Dysphonia 3.3%
Hemiparesis 3.3%
Concomitant
Product Used For Unknown Indication 42.0%
Asthma 12.9%
Chronic Obstructive Pulmonary Disease 11.5%
Hypertension 6.0%
Pain 3.4%
Atrial Fibrillation 2.8%
Prophylaxis 2.5%
Osteoporosis 2.2%
Depression 2.1%
Diabetes Mellitus 1.8%
Rheumatoid Arthritis 1.7%
Hepatitis C 1.5%
Non-small Cell Lung Cancer 1.5%
Behcet's Syndrome 1.4%
Breast Cancer 1.4%
Mental Disorder 1.1%
Multiple Myeloma 1.1%
Dyspnoea 1.1%
Bronchitis 0.9%
Gastrooesophageal Reflux Disease 0.9%
Asthma 12.9%
Death 7.1%
Chronic Obstructive Pulmonary Disease 6.7%
Dyspnoea 6.3%
Cardiac Arrest 5.8%
Renal Failure Acute 5.8%
Abdominal Pain Upper 4.9%
Diarrhoea 4.9%
Pneumonia 4.9%
Cerebrovascular Accident 4.5%
General Physical Health Deterioration 4.0%
Pyrexia 4.0%
Renal Impairment 4.0%
Drug Interaction 3.6%
Headache 3.6%
Lower Respiratory Tract Infection 3.6%
Pain 3.6%
Thrombocytopenia 3.6%
Cough 3.1%
Drug Ineffective 3.1%
Interacting
Hiv Infection 66.7%
Asthma 33.3%
Labelled Drug-drug Interaction Medication Error 50.0%
Muscle Atrophy 50.0%